SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-370863
Filing Date
2017-12-15
Accepted
2017-12-15 17:17:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 d493039ds3a.htm S-3/A 401251
2 EX-5.1 d493039dex51.htm EX-5.1 12091
3 EX-5.2 d493039dex52.htm EX-5.2 20543
4 EX-23.1 d493039dex231.htm EX-23.1 1827
5 GRAPHIC g493039dsp058.jpg GRAPHIC 3071
6 GRAPHIC g493039g44y37.jpg GRAPHIC 34869
  Complete submission text file 0001193125-17-370863.txt   489207
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: S-3/A | Act: 33 | File No.: 333-221526 | Film No.: 171259804
SIC: 2834 Pharmaceutical Preparations